Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 17/20 | 0.48 |
| ▸ | CNR2 | P34972 | 14/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6769520 | 0.93 | CNR1 (0.57) | CNR1CNR2KDM4EMEN1MAPT | |
| SCHEMBL5768402 | 0.83 | CNR1 (0.51) | CNR1CNR2KDM4EMEN1MAPT | |
| SCHEMBL5766389 | 0.81 | CNR1 (0.54) | CNR1CNR2 | |
| SCHEMBL5767553 | 0.81 | CNR1 (0.54) | CNR1CNR2KDM4EMEN1MAPT | |
| SCHEMBL5769679 | 0.79 | CNR1 (0.47) | CNR1CNR2 | |
| SCHEMBL5769125 | 0.79 | CNR1 (0.49) | CNR1CNR2KDM4EMEN1MAPT | |
| SCHEMBL5767540 | 0.77 | CNR1 (0.50) | CNR1CNR2 | |
| SCHEMBL6766971 | 0.76 | CNR1 (0.52) | CNR1CNR2KDM4EMEN1MAPT | |
| SCHEMBL5768882 | 0.76 | CNR1 (0.50) | CNR1CNR2 | |
| SCHEMBL5766942 | 0.75 | CNR1 (0.52) | CNR1CNR2KDM4EMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1622876-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | Pfizer Products Inc. (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004099157-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | PFIZER PRODUCTS INC. (US) | 2004-11-18 | — | — | WO | disclosed |